Curriculum‎ > ‎Electives‎ > ‎

Endocrinology

The Endocrine elective is offered to PGY2's and PGY3's as a 2 or 4 week elective at Moses and Weiler campus (at discretion of elective coordinators).

Weekly Didactic and Clinic Schedule:
Monday
8-9- Diabetes Clinical Conference at CFCC
9-12-General Endocrinology Clinic at CFCC
1-330- Inpatients Consults **
4-5-Endocrine Fellows Conference (See Schedule for exact dates/locations of conferences – Held September – May only)

Tuesday
9-12- Inpatient Consults
1-5- Jacobi Endocrinology Clinic in Building 5, 3rd Fl./A-wing
Wednesday
9-5 Inpatient Consults, independent study, conference preparation

Thursday
8:15-9 Diabetes Journal Club* at Montefiore at DTC, 460
9-12 Diabetes Clinic at Montefiore at DTC, 460
1-5 Inpatient Consults

Friday
8-9 Endocrine Conference* at Belfer 712
9-10 Diabetes Research Conference at Belfer, 712 (Held September – May only)
10-1 Inpatient Consults**
1-4 Endocrine Clinic at Montefiore at DTC, 460
4-5 Endocrine Conference at Montefiore at DTC, 460

Goals and Objectives

*You are expected to present one diabetes journal club and one endocrinology case during your rotation.

** Time blocked for inpatient consults will include attending rounds, independent reading and preparation for conferences. Patients that you see in consultation should be followed until resolution of their primary endocrine issues.

 Trainees are encouraged to use major textbooks and electronic resources as suggested by the faculty.  These include the textbooks of Endocrinology (Williams or Becker), The Thyroid (Braverman and Utiger), UpToDate, Thyroid disease Manager, practice guidelines of the American Thyroid Association (), American Association of Clinical Endocrinologists (www.AACE.com), and American Diabetes Association ( . Trainees are encouraged to read monthly the Journal of Clinical Endocrinology and Metabolism, Endocrine Reviews, THYROID, DIABETES, Diabetes Care, the Journal of Clinical Investigation and others depending on thei r specific interests.

All Journals are available electronically through the Samuel Gottesman Library at the Albert Einstein College of Medicine.

Two available resources may be used as supplementary teaching materials, if deemed necessary by the Program Director. These are the publications: (1) Care of the Dying and Promotion of Physician Competency- Educational Resource and Personal Narratives, published by the American Board of Internal Medicine (), and (2) EPEC (Education for Physicians on End-of-life Care), published jointly by the Robert Wood Johnson Foundation and the American Medical Association (www.ama-assn.org/ethic/epec ).

Diabetes Mellitus

Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V 1999 New profiles of diabetic ketoacidosis.  Type 1 vs Type 2 diabetes and the effect of ethnicity.  Arch Intern Med 159:2317-2322.

Golan L, Birkmeyer JD, Welch HG 1999 The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Int Med 131:660-667.

DCCT Research Group 2000 Retinopathy and nephropathy in patients with type I diabetes four years after a trial of intensive therapy.  N Engl J Med 342:381-9.

Detre KM, Lombardero MS, Brooks MM, et al 2000 The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction.  N Engl J Med 342:989-997.

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus:  results of the HOPE study and MICRO-HOPE substudy.  Lancet  355:253, 2000

Langer O, Conway DL, Berkus MD, et al 2000 A comparison of glyburide and insulin in women with gestational diabetes mellitus.  N Engl J Med 343:1134-1138.

Mogensen CE, Neldam S, Tikkanen I, et al 2000 Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes:  the candesartan and lisinopril microalbuminuria (CALM) study.  Brit Med J 321:1440-1444.

Skyler J, et al 2001 Efficacy of inhaled human insulin in type 1 diabetes mellitus:  a randomized proof-of-concept study.  Lancet 357:331-335.

Malone JL, Pavan PR, Morrison AD, Cuthbertson DD 2001 Prevalence and significance of retinopathy in subjects with type I diabetes of less than 5 years' duration screened for the Diabetes Control and Complications Trial.  Diabetes Care 24(3):522-526.

Greet Van den Berghe, et al 2001 Intensive insulin therapy in critically ill patients.  N Engl J Med 345:1359-1367.

Bone and Mineral

Ravn P, Bidstrup M, Wasnich RD, et al. 1999  Alendronate and estrogen-progestin in the long-term prevention of bone loss:  four-year results from the early postmenopausal intervention cohort study.  Ann Intern Med 131:935-942.

Schairer C, Lubin J, Troisi R, et al. 2000 Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.  JAMA 283:485-491.

McClung MR, et al 2001 Effect of risedronate on the risk of hip fracture in elderly women.  N Engl J Med 344:333-340.

Bauer DC, Ettinger B, Nevitt MC, et al 2001 Risk for fracture in women with low serum levels of thyroid-stimulating hormone.  Ann Intern Med 134:561-568.

Israel E, et al 2001 Effects of inhaled glucocorticoids on bone density in pre-menopausal women.  N Engl J Med 345:941-947.

 

Thyroid

Parle JV, et al 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result:  a 10-year cohort study.  Lancet 358:861-865.

Sachmechi I, Miller E, Varatharajah R, et al 2000 thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters.  Endocr Pract 6:5-7.

Subpages (1): Goals and Objectives
Comments